Quick Answer
TRINITY BIOTECH PLC reported Research And Development Expense of $4.54 million for the year ending 2024.
- TRINITY BIOTECH PLC showed an increase of +3.7% in Research And Development Expense from 2023 to 2024.
- This data is from TRINITY BIOTECH PLC's annual report (Form 10-K), filed with the SEC on May 16, 2025.
- XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2015 to 2024), TRINITY BIOTECH PLC's Research And Development Expense has declined by 10.4%.
- Historical annual values: Fiscal year 2024: $4.54 million | Fiscal year 2023: $4.38 million | Fiscal year 2022: $4.14 million | Fiscal year 2021: $4.50 million | Fiscal year 2020: $5.08 million | Fiscal year 2019: $5.33 million | Fiscal year 2018: $5.37 million | Fiscal year 2017: $5.66 million | Fiscal year 2016: $5.04 million | Fiscal year 2015: $5.07 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: